AU6410494A - Device for the transdermal administration of alprazolam - Google Patents

Device for the transdermal administration of alprazolam

Info

Publication number
AU6410494A
AU6410494A AU64104/94A AU6410494A AU6410494A AU 6410494 A AU6410494 A AU 6410494A AU 64104/94 A AU64104/94 A AU 64104/94A AU 6410494 A AU6410494 A AU 6410494A AU 6410494 A AU6410494 A AU 6410494A
Authority
AU
Australia
Prior art keywords
alprazolam
transdermal administration
transdermal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64104/94A
Inventor
Nieves Marzan Crisologo
Lina Tormen Taskovich
Tyler Watanabe
Su Il Yum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AU6410494A publication Critical patent/AU6410494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU64104/94A 1993-03-17 1994-03-17 Device for the transdermal administration of alprazolam Abandoned AU6410494A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3236393A 1993-03-17 1993-03-17
US032363 1993-03-17
US12842093A 1993-09-29 1993-09-29
US128420 1993-09-29
PCT/US1994/002880 WO1994021262A1 (en) 1993-03-17 1994-03-17 Device for the transdermal administration of alprazolam

Publications (1)

Publication Number Publication Date
AU6410494A true AU6410494A (en) 1994-10-11

Family

ID=26708328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64104/94A Abandoned AU6410494A (en) 1993-03-17 1994-03-17 Device for the transdermal administration of alprazolam

Country Status (2)

Country Link
AU (1) AU6410494A (en)
WO (1) WO1994021262A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
ES2259746T3 (en) * 1996-07-15 2006-10-16 Alza Corporation NEW FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FLUOXETINA.
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
PT1152749E (en) 1999-02-08 2006-08-31 Alza Corp VISCOUS EXCIPIENTS STABLE, NOT AQUEOUS AND FORMULAS USING SUCH EXCIPIENTS
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
CN100402036C (en) * 2004-04-26 2008-07-16 袁重华 Coating agent for treating insomnia and its usage
ES2265239B1 (en) * 2004-09-23 2008-02-01 Laboratorio Reig Jofre, S.A. PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION.
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DK2020990T3 (en) 2006-05-30 2010-12-13 Intarcia Therapeutics Inc An internal channel flow modulator for a two-part osmotic feeding system
CA2670821C (en) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
MX2009011123A (en) 2007-04-23 2009-11-02 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof.
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
KR101823699B1 (en) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
ATE77559T1 (en) * 1986-11-14 1992-07-15 Theratech Inc INCREASE OF PENETRATION BY MEANS OF A BINARY SYSTEM CONSISTING OF CELL-CELL MODIFICATION SUBSTANCES AND SHORT-CHAIN ALCOHOLS.
US5225198A (en) * 1991-08-27 1993-07-06 Cygnus Therapeutic Systems Transdermal administration of short or intermediate half-life benzodiazepines

Also Published As

Publication number Publication date
WO1994021262A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU6410494A (en) Device for the transdermal administration of alprazolam
AU7137694A (en) Anchoring device
AU5189893A (en) Catheter device
AU6867794A (en) Improved retaining device
AU6508194A (en) Transintimal recanalisation device
AU5135193A (en) Encryption device
AU2109195A (en) Two-component device for the administration of drugs
AU7545594A (en) Implantable device for the treatment of aedemas
AU7678894A (en) Silicon carbide field effect device
AU3675293A (en) Massaging device
AU4083993A (en) Dose indicating device
AU680556B2 (en) Locking device
AU6794494A (en) Massage device
AU1444092A (en) Drop-producing device
AU4388093A (en) Integrated field-effect initiator
AU4656596A (en) Transdermal formulation
AU4774296A (en) Transdermal formulation
AU3109489A (en) Tightening device
AU4914396A (en) Transdermal formulation
AU3258793A (en) Foam-spraying device
AU1206595A (en) Measuring device
AU6389394A (en) Theft-impairing device
AU6706994A (en) Dressing-aid-and-transfer device
AU5171893A (en) Theft-detection device
AU4949093A (en) Tinnitus-treatment device